Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_assertion description "[ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_assertion evidence source_evidence_literature NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_assertion SIO_000772 15867198 NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_assertion wasDerivedFrom befree-20150227 NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_assertion wasGeneratedBy ECO_0000203 NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP576823.RA48zwA7xhIX-F4K9AksSi2EcYE7G_143EbAj7XjIjPTg130_provenance.